Simplex Trading’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-258
| Closed | -$63K | – | 10647 |
|
|
2020
Q4 | $63K | Buy |
258
+158
| +158% | +$385 | ﹤0.01% | 5943 |
|
|
2020
Q3 | $31K | Buy |
+100
| New | +$319 | ﹤0.01% | 6057 |
|
|
2020
Q2 | – | Sell |
-31
| Closed | -$8K | – | 8879 |
|
|
2020
Q1 | $8K | Sell |
31
-25
| -45% | -$81 | ﹤0.01% | 6647 |
|
|
2019
Q4 | $18K | Sell |
56
-4
| -7% | -$12 | ﹤0.01% | 6050 |
|
|
2019
Q3 | $12K | Buy |
60
+46
| +329% | +$123 | ﹤0.01% | 6176 |
|
|
2019
Q2 | $4K | Sell |
14
-57
| -80% | -$185 | ﹤0.01% | 6606 |
|
|
2019
Q1 | $26K | Sell |
71
-30
| -30% | -$101 | ﹤0.01% | 5547 |
|
|
2018
Q4 | $29K | Sell |
101
-21
| -17% | -$58 | ﹤0.01% | 5035 |
|
|
2018
Q3 | $32K | Buy |
122
+117
| +2,340% | +$287 | ﹤0.01% | 5606 |
|
|
2018
Q2 | $1K | Sell |
5
-352
| -99% | -$983 | ﹤0.01% | 7272 |
|
|
2018
Q1 | $14K | Buy |
357
+210
| +143% | +$573 | ﹤0.01% | 3750 |
|
|
2017
Q4 | $1K | Buy |
147
+26
| +21% | +$80 | ﹤0.01% | 5865 |
|
|
2017
Q3 | $3K | Buy |
121
+15
| +14% | +$42 | ﹤0.01% | 4970 |
|
|
2017
Q2 | $5K | Buy |
+106
| New | +$244 | ﹤0.01% | 4700 |
|
|
2016
Q3 | – | Sell |
-230
| Closed | -$2K | – | 7116 |
|
|
2016
Q2 | $2K | Buy |
230
+161
| +233% | +$537 | ﹤0.01% | 5149 |
|
|
2016
Q1 | $1K | Sell |
69
-75
| -52% | -$234 | ﹤0.01% | 5436 |
|
|
2015
Q4 | $1K | Buy |
+144
| New | +$603 | ﹤0.01% | 5242 |
|
|
2015
Q1 | – | Sell |
-95
| Closed | -$1K | – | 6341 |
|
|
2014
Q4 | $1K | Buy |
+95
| New | +$752 | ﹤0.01% | 4562 |
|
Other funds holding PDLI
Simplex Trading's PDLI Position: Q1 2021 in Review
Simplex Trading sold out of PDL BioPharma, Inc. (PDLI) in Q1 2021, closing a stake of 9,482 shares — an estimated $23K sold.
Simplex Trading first reported a position in PDLI in Q4 2014 and held it in 12 quarters. The position peaked at $129K in Q1 2015. 11 funds tracked by Wall St. Rank hold PDLI as of Q1 2021.
- Simplex Trading reported no remaining PDL BioPharma, Inc. position as of Q1 2021 after selling out during the quarter.
- Simplex Trading sold 9,482 PDL BioPharma, Inc. shares in Q1 2021, an estimated $23K.
- Simplex Trading first reported a position in PDL BioPharma, Inc. in Q4 2014 and held it in 12 quarters.
- Simplex Trading's PDL BioPharma, Inc. position peaked at $129K in Q1 2015.
- 11 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2021.
Based on Simplex Trading's 13F filing for Q1 2021, filed 26 Apr 2021.